These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9862407)

  • 1. Comparison of the discriminative and antinociceptive effects of morphine and its glucuronide metabolites after central or systemic administration in the rat.
    Easterling KW; Holtzman SG
    Psychopharmacology (Berl); 1998 Nov; 140(1):91-7. PubMed ID: 9862407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central discriminative effects of morphine in rats: training via intracerebroventricular administration.
    Easterling KW; Holtzman SG
    Brain Res Bull; 2001 Dec; 56(6):545-51. PubMed ID: 11786240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the discriminative stimulus effects of centrally administered morphine in the rat.
    Locke KW; Holtzman SG
    Psychopharmacology (Berl); 1985; 87(1):1-6. PubMed ID: 2997824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat.
    Van Crugten JT; Somogyi AA; Nation RL; Reynolds G
    Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats.
    Abbott FV; Palmour RM
    Life Sci; 1988; 43(21):1685-95. PubMed ID: 2848167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of morphine-6-glucuronide antinociception after morphine treatment. Is morphine-3-glucuronide involved?
    Faura CC; Olaso JM; Cabanes CG; Horga JF
    Pain; 1996 Apr; 65(1):25-30. PubMed ID: 8826486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine metabolites.
    Christrup LL
    Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 2):116-22. PubMed ID: 9061094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of metabolic effects of morphine-6-glucuronide by morphine-3-glucuronide.
    Hashiguchi Y; Molina PE; Abumrad NN
    Brain Res Bull; 1995; 38(4):325-9. PubMed ID: 8535854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat.
    Qian-Ling G; Hedner J; Björkman R; Hedner T
    Pain; 1992 Feb; 48(2):249-255. PubMed ID: 1589243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration-effect relationships of morphine and morphine-6 beta-glucuronide in the rat.
    van Crugten JT; Somogyi AA; Nation RL; Reynolds G
    Clin Exp Pharmacol Physiol; 1997 May; 24(5):359-64. PubMed ID: 9143788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent insensitivity of the hotplate latency test for detection of antinociception following intraperitoneal, intravenous or intracerebroventricular M6G administration to rats.
    South SM; Smith MT
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1326-32. PubMed ID: 9732396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of morphine metabolites on micturition in normal, unanaesthetized rats.
    Igawa Y; Westerling D; Mattiasson A; Andersson KE
    Br J Pharmacol; 1993 Sep; 110(1):257-62. PubMed ID: 8220887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-dependent influences of morphine and its metabolites on pain sensitivity in the rat.
    Doyle HH; Murphy AZ
    Physiol Behav; 2018 Apr; 187():32-41. PubMed ID: 29199028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine.
    Frances B; Gout R; Monsarrat B; Cros J; Zajac JM
    J Pharmacol Exp Ther; 1992 Jul; 262(1):25-31. PubMed ID: 1320685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine-6 beta-glucuronide induces potent immunomodulation.
    Carrigan KA; Lysle DT
    Int Immunopharmacol; 2001 May; 1(5):821-31. PubMed ID: 11379038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute and chronic administration of L-arginine on the antinociceptive action of morphine-6-beta-D-glucuronide.
    Bhargava HN; Bian JT
    Pharmacology; 1997 Oct; 55(4):165-72. PubMed ID: 9396075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of neuropeptide Y on the discriminative stimulus and antinociceptive properties of morphine.
    Picker MJ; Allen RM; Morgan D; Levine AS; O'Hare E; Cleary JP
    Pharmacol Biochem Behav; 1999 Sep; 64(1):161-4. PubMed ID: 10495011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potency ratios of morphine and morphine-6beta-glucuronide analgesia elicited from the periaqueductal gray, locus coeruleus or rostral ventromedial medulla of rats.
    Krzanowska EK; Rossi GC; Pasternak GW; Bodnar RJ
    Brain Res; 1998 Jul; 799(2):329-33. PubMed ID: 9675330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The excitatory behavioral and antianalgesic pharmacology of normorphine-3-glucuronide after intracerebroventricular administration to rats.
    Smith GD; Smith MT
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1157-62. PubMed ID: 9618418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine-3-glucuronide: evidence to support its putative role in the development of tolerance to the antinociceptive effects of morphine in the rat.
    Smith GD; Smith MT
    Pain; 1995 Jul; 62(1):51-60. PubMed ID: 7478708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.